改善冠心病和慢性心力衰竭患者的生活质量:以米屈酸钠为重点

Medicinskij alfavit Pub Date : 2023-11-11 DOI:10.33667/2078-5631-2023-25-21-25

N. V. Teplova, A. G. Vardanyan, V. O. Grigoryan

{"title":"改善冠心病和慢性心力衰竭患者的生活质量:以米屈酸钠为重点","authors":"N. V. Teplova, A. G. Vardanyan, V. O. Grigoryan","doi":"10.33667/2078-5631-2023-25-21-25","DOIUrl":null,"url":null,"abstract":"This article describes clinical cases of patients with ischemic heart disease complicated by severe chronic heart failure during basic therapy with the inclusion of Mildronate. The results of the treatment prove the effectiveness of the use of this drug, in the form of an increase in exercise tolerance, regression of CHF phenomena, and improvement in the quality of life of patients with a burdened cardiovascular history.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"24 8","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving quality of life in patients with CHD and CHF: Focusing on mildronate\",\"authors\":\"N. V. Teplova, A. G. Vardanyan, V. O. Grigoryan\",\"doi\":\"10.33667/2078-5631-2023-25-21-25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This article describes clinical cases of patients with ischemic heart disease complicated by severe chronic heart failure during basic therapy with the inclusion of Mildronate. The results of the treatment prove the effectiveness of the use of this drug, in the form of an increase in exercise tolerance, regression of CHF phenomena, and improvement in the quality of life of patients with a burdened cardiovascular history.\",\"PeriodicalId\":499576,\"journal\":{\"name\":\"Medicinskij alfavit\",\"volume\":\"24 8\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinskij alfavit\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33667/2078-5631-2023-25-21-25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinskij alfavit","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33667/2078-5631-2023-25-21-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文描述了缺血性心脏病合并严重慢性心力衰竭患者在米地膦酸钠基础治疗期间的临床病例。治疗结果证明了使用该药物的有效性，表现为运动耐量增加，CHF现象消退，有心血管病史患者的生活质量改善。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Improving quality of life in patients with CHD and CHF: Focusing on mildronate

This article describes clinical cases of patients with ischemic heart disease complicated by severe chronic heart failure during basic therapy with the inclusion of Mildronate. The results of the treatment prove the effectiveness of the use of this drug, in the form of an increase in exercise tolerance, regression of CHF phenomena, and improvement in the quality of life of patients with a burdened cardiovascular history.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medicinskij alfavit

自引率

0.00%

发文量